Simris Group Feed

2026-02-28 08:00:00 SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2025

2026-01-19 16:30:00 Bulletin from Simris Group AB’s extraordinary general meeting 0,04 SEK | +0,93% | 0,08 MSEK

2026-01-19 14:00:00 Simris Group enters into Memorandum of Understanding regarding divestment of assets in Hammenhög 0,04 SEK | +0,93% | 0,08 MSEK

2025-12-16 21:32:00 Simris Group AB (publ) receives notice of conversion of convertible bonds 0,04 SEK | -49,77% | 2,07 MSEK

2025-12-16 20:45:00 Notice of extraordinary general meeting in Simris Group AB (publ) 0,04 SEK | -49,77% | 2,07 MSEK

2025-12-16 20:43:00 Simris Group AB resolves on directed issue of units, proposes that an extraordinary general meeting resolves on additional share issues and announces acceptance of premature conversion of convertible debentures 0,04 SEK | -49,77% | 2,07 MSEK

2025-11-28 16:51:00 Simris Group enters into bridge loan agreement 0,09 SEK | -14,83% | 0,01 MSEK

2025-11-12 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-SEPTEMBER 2025 0,11 SEK | -0,44% | 0,07 MSEK

2025-11-10 08:30:00 Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO 0,11 SEK | +4,76% | 0,02 MSEK

2025-11-05 13:00:00 Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan 0,10 SEK | +8,70% | 0,30 MSEK

2025-10-06 09:30:00 Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads 0,12 SEK | -3,16% | 0,11 MSEK

2025-09-12 10:00:00 Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) 0,15 SEK | +25,51% | 0,14 MSEK

2025-08-13 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-JUNE 2025 0,16 SEK | -0,63% | 0,06 MSEK

2025-07-27 21:57:00 Simris Group AB (publ) resolves on a directed issue of convertible debentures of EUR 678,000 and amends existing loan facilities 0,17 SEK | +1,80% | 0,01 MSEK

2025-07-12 06:38:00 Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review

2025-06-05 09:15:00 Simris Biologics Signs Agreement with Nuvisan for In-Vivo Evaluation of Novel Microcystin Payloads 0,13 SEK | +18,18% | 0,12 MSEK

2025-06-02 08:55:00 Simris Group AB Signs Non-Binding Concept Sheet for Potential Antibody-Drug Conjugate Collaboration 0,09 SEK | +16,79% | 0,10 MSEK

2025-05-28 17:10:00 Bulletin from Simris Group AB’s annual general meeting 0,08 SEK | +1,29% | 0,01 MSEK

2025-05-14 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2025 0,07 SEK | -9,76% | 0,08 MSEK

2025-04-25 15:00:00 Notice of the Annual General Meeting of Simris Group AB (publ) 0,10 SEK | 0,00% | 0,00 MSEK

2025-04-16 18:05:00 Simris Group enters into bridge loan agreement, extends loan agreements with investors and intends to propose that the annual general meeting resolves to extend loan agreements with management 0,09 SEK | +0,21% | 0,01 MSEK

2025-04-16 15:00:00 SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2024 0,09 SEK | -0,21% | 0,00 MSEK

2025-03-25 08:00:00 Refined Microcystin Payloads Show Promising In-Vitro Efficacy, Paving Way for Next-Generation Variants 0,13 SEK | +13,51% | 0,04 MSEK

2025-02-26 08:00:00 SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2024 0,09 SEK | +2,26% | 0,01 MSEK

2025-01-20 14:18:00 Bulletin from Simris Group AB’s Extraordinary General Meeting 0,09 SEK | +3,33% | 0,01 MSEK

2024-12-23 11:07:00 Notice of Extraordinary General Meeting of Simris Group AB (publ) 0,09 SEK | +71,31% | 0,23 MSEK

2024-12-23 09:44:00 Simris resolves on a share issue, repayment of convertible debentures, prolongation of loan agreements, entering into and to call for a general meeting to resolve to enter into new loan agreements 0,09 SEK | +71,31% | 0,23 MSEK

2024-11-13 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-SEPTEMBER 2024 0,12 SEK | +32,61% | 0,12 MSEK

2024-10-23 18:04:00 Uncertainty regarding when the next payment from the agreed loan facility can occur 0,09 SEK | -10,75% | 0,04 MSEK

2024-10-18 18:22:00 Simris Group chairman and major owner Steven Schapera has passed away after complications after surgery

2024-09-09 08:00:00 Simris Biologics awarded funding for a research collaboration with Berlin's University of Applied Science to explore the ability of natural compounds from Cyanobacteria to delay aging 0,13 SEK | +10,64% | 0,05 MSEK

2024-08-14 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-JUNE 2024 0,14 SEK | +0,37% | 0,04 MSEK

2024-07-09 15:45:00 Simris Biologics enters into a collaboration agreement with New Zealand Universities to develop peptide drug conjugates (PDC) 0,16 SEK | +9,12% | 0,12 MSEK

2024-06-28 11:15:00 Bulletin from Simris Group AB (publ)’s Annual General Meeting 0,16 SEK | -0,31% | 0,01 MSEK

2024-05-27 18:35:00 Notice of the Annual General Meeting of Simris Group AB (publ) 0,17 SEK | -16,54% | 0,17 MSEK

2024-05-15 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2024 0,16 SEK | +32,92% | 0,05 MSEK

2024-04-29 14:00:00 SIMRIS GROUP AB ANNOUNCED TODAY THAT THE BOARD HAS DECIDED TO MOVE THE COMPANY'S ANNUAL GENERAL MEETING FROM MAY 29, 2024 TO JUNE 28, 2024 0,13 SEK | 0,00% | 0,03 MSEK

2024-04-23 14:10:00 Simris Group AB (publ) announces the outcome of the directed offer of convertible debentures 0,13 SEK | -5,62% | 0,06 MSEK

2024-04-17 14:45:00 SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2023 0,13 SEK | +0,38% | 0,01 MSEK

2024-04-15 20:30:00 SIMRIS GROUP CONFIRMS A TERM EXTENSION TO FLEXIBLE FUNDING FACILITY 0,13 SEK | -1,12% | 0,02 MSEK

2024-04-05 11:15:00 Bulletin from Simris Group’s Extraordinary General Meeting 0,14 SEK | -11,18% | 0,04 MSEK

2024-03-19 19:33:00 Notice of Extraordinary General Meeting of Simris Group AB (publ) 0,13 SEK | -9,03% | 0,01 MSEK

2024-03-15 21:34:00 The board of Simris Group AB (publ) resolves to change the terms of the directed issue of convertible debentures by increasing from EUR 1.0m to EUR €1.15m subject to the approval of the general meeting. 0,15 SEK | +5,15%

2024-03-14 18:35:00 The board of Simris Group AB (publ) resolves on a directed issue of convertible debentures up to EUR 1,000,000 subject to the approval of the General Meeting. 0,15 SEK | +1,75% | 0,10 MSEK

2024-03-12 21:10:00 Julian Read steps down as CEO of Simris Group. The Board of Simris appoints Dr Alexis Roberts-McIntosh as his successor with immediate effect. 0,13 SEK | +10,43% | 0,08 MSEK

2024-03-06 09:02:00 Simris Group AB confirms that it will temporarily pause production at its facility in Hammenhög, Sweden 0,16 SEK | -23,57% | 0,32 MSEK

2024-02-28 08:00:00 SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2023 0,22 SEK | -2,65% | 0,11 MSEK

2024-01-10 08:00:00 Simris signs Head of Terms for an offtake agreement valued at minimum €2m / SEK 22m 0,24 SEK | +7,46% | 0,10 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Simris Group

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden